Paclitaxel Injection

Product Price :Get Latest Price

Product BrochureBeing one of the glorious names of the field, we are involved in manufacturing, exporting and supplying Paclitaxel Injection 300mg in standardized packaging. Processed under hygienic environmental conditions, the proposed compilation is massively applauded for its supreme effectiveness and enhanced shelf life. These injections play a vital role in treating NSCLC, ovarian cancer, aids-related kaposi sarcoma and breast cancer.

Features:

• Longer shelf life
• Precise pH value
• Hygienically prepared

Indications:

• Ovarian Cancer
• NSCLC
• Breast Cancer
• AIDS-related Kaposi Sarcoma

Dosage and Administration:

Ovarian Cancer:

• For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
• Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
• Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
• In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks.

Breast Cancer:

• For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin-containing combination chemotherapy
• After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks.

NSCLC:

• Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

AIDS-related Kaposi Sarcoma:

• Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week).
• Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)

Product Price :Get Latest Price

Product BrochureBacked by a team of skilled and experienced professionals, we are involved in proffering hygienically processed and packed Paclitaxel Injection 30mg. Prepared as per the existing industrial procedures, these effective injections are immensely popular for treating ovarian & breast cancer, NSCLC and aids-related kaposi sarcoma. To avoid contaminants, we provide the batch in standardized packaging.

Features:

• Extended shelf life
• Correct chemical composition
• Effective results

Indications:

• Ovarian Cancer
• NSCLC
• Breast Cancer
• AIDS-related Kaposi Sarcoma

Dosage and Administration:

Ovarian Cancer:

• For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
• Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
• Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
• In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks

Breast Cancer:

• For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin- containing combination chemotherapy
• After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks

NSCLC:

• Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

AIDS-related Kaposi Sarcoma:

• Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week)
• Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)

Product Price :Get Latest Price

Product BrochureWe are concerned with the manufacture, export and supply of Paclitaxel Injection 100mg that is made available in different packaging quantities. Widely used for curing ovarian cancer, breast cancer, NSCLC and aids-related kaposi sarcoma, the proffered batch of injection is massively asked for. In order to prevent harmful chemicals and contaminants, we offer the batch in tamper proof packaging.

Features:

• Extended shelf life
• Accurate chemical formulation
• High effectiveness

Indications:

• Ovarian Cancer
• NSCLC
• Breast Cancer
• AIDS-related Kaposi Sarcoma

Dosage and Administration:

Ovarian Cancer:

• For previously untreated patients with carcinoma of ovary, 1 of the following recommended regimens may be given every 3 weeks
• Paclitaxel 175mg/m2 administered IV over 3 hrs followed by Cisplatin 75mg/m2
• Paclitaxel 135mg/m2 administered IV over 24 hours followed by Cisplatin 75mg/m2
• In patients previously treated with chemotherapy for carcinoma of the ovary, recommended regimen is paclitaxel 135-175 mg/m2 administered IV over 3 hours every 3 weeks.

Breast Cancer:

• For The adjuvant-treatment of node-positive Breast Cancer, the recommended regimen is paclitaxel 175mg/m2 IV over 3 hours every 3 weeks for 4 courses administered sequentially to doxorubicin- containing combination chemotherapy
• After failure of initial chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy, paclitaxel 175mg/m2 administered IV over 3 hours every 3 weeks.

NSCLC:

• Given every 3 weeks, Paclitaxel 315 mg/m2 is administered IV over 24 hrs followed by Cisplatin 75 mg/m2

AIDS-related Kaposi Sarcoma:

• Paclitaxel 135 mg/m2 given IV over 3 hours every 2 weeks is recommended (dose intensity 45-50 mg /m2 /week).
• Paclitec to patients with AIDS-related Kaposi sarcoma if the base count or subsequent neutrophil count is less than 1,000 cells /mm3, 2- Reduce the dose of Dexamethasone (as 1 of the 3 premedication drugs) to 10mg orally (instead of 20 mg orally)